The role of monocytes and macrophages in age-related macular degeneration

Michelle Grunin1, Shira Hagbi-Levi, Itay Chowers

  • 1Department of Ophthalmology, Hadassah-Hebrew University Medical Center, 91120, Jerusalem, Israel, michelle.grunin@mail.huji.ac.il.

Insights

Monocytes and macrophages are key players in age-related macular degeneration (AMD). Understanding their role and the chemokine receptors involved may help modulate AMD progression.

Area of Science:

  • Ophthalmology
  • Immunology
  • Cell Biology

Background:

  • Age-related macular degeneration (AMD) is a leading cause of vision loss.
  • White blood cells, specifically monocytes and macrophages, are increasingly recognized for their role in AMD pathogenesis.

Purpose of the Study:

  • To review the current understanding of monocyte and macrophage involvement in AMD.
  • To explore the function of chemokine receptors (CCR1, CCR2, CX3CR1) in recruiting these cells to sites of inflammation in AMD.
  • To discuss relevant mouse models for studying AMD.

Main Methods:

  • Literature review of human and rodent studies.
  • Analysis of the role of specific chemokine receptors (CCR1, CCR2, CX3CR1).
  • Examination of mouse models mimicking AMD features.

Main Results:

  • Monocytes and macrophages are implicated in AMD pathology.
  • Chemokine receptors (CCR1, CCR2, CX3CR1) are crucial for monocyte/macrophage recruitment in AMD.
  • Mouse models provide insights into AMD mechanisms.

Conclusions:

  • Evidence suggests monocytes and macrophages significantly influence the course of AMD.
  • Targeting chemokine receptors may offer therapeutic strategies for AMD.